Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

NCT04863664 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT04863664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Not applicable
Overall status
Completed
Start date
June 21, 2021
Completion date
November 6, 2025
Enrollment
998 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

tachyarrhythmia